Diamond Orthopedic closed a US $3.5MM seed round of equity funding. The company has exclusive rights to market >2,500 FDA-cleared SKUs of cortical, cancellous, headless compression and external fixation screws.
The company's technologies are based on a faceted threadform that reportedly demonstrates superior performance vs. conventional helical designs. The faceted characteristics are intended to reduce friction and stress where the bone and screw meet, thus reducing the risk of microfractures.
The capital raise was led by MagnaSci Fund.
Source: Diamond Orthopedic, LLC